It is a pharma private limited company based in Kollam, Kerala, India, established in 1993.
1993 | Kollam, Kerala, India | ActiveRevathy Pharma Pvt Ltd, a active private limited company, was established on 15 July 1993 in Kollam, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KL1993PTC007245. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.39 M.
It upholds a compliant status. Its leadership includes Biju Sreedharan Pillai (Managing Director), Santhamma Govinda Pillai (Director). It holds ₹6.38 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Maruthamon Veedukanjirakode Kundara, Kollam, Kerala, 691501.
U24231KL1993PTC007245
007245
15 July 1993
₹1.00 M
₹0.39 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Revathy Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Biju Sreedharan Pillai | Managing Director | 29 Apr 1997 | Current |
| Santhamma Govinda Pillai | Director | 18 Jan 2002 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Revathy Pharma Pvt Ltd, for the financial year ended 2020, experienced significant growth in revenue, with a 13.48% increase. The company also saw a substantial improvement in profitability, with a 14% increase in profit. The company's net worth moved up by a moderate rise of 7.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Revathy Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,375,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2021 | Canara Bank | ₹0.50 M | Open |
| 24 Jun 2020 | Canara Bank | ₹0.90 M | Open |
| 12 Oct 2010 | Canara Bank | ₹0.48 M | Open |
| 04 Nov 1997 | Canara Bank | ₹4.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Revathy Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Revathy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revathy Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Revathy Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Revathy Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 0.50 M with Charge ID 100505447 was registered on 06 Nov 2021. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 0.90 M with Charge ID 100381154 was registered on 24 Jun 2020. was recorded as a recent event.
A charge with Canara Bank of Rs. 4.50 M registered on 04 Nov 1997 with Charge ID 90016974 was modified on 28 Oct 2015. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.48 M with Charge ID 10251883 was registered on 12 Oct 2010. was documented.
The CIN of Revathy Pharma Pvt Ltd is U24231KL1993PTC007245.
Revathy Pharma Pvt Ltd is headquartered at Maruthamon Veedukanjirakode Kundara, Kollam, Kerala, 691501.
Revathy Pharma Pvt Ltd was incorporated on 15 July 1993.
The current directors of Revathy Pharma Pvt Ltd are
The primary industry of Revathy Pharma Pvt Ltd is Manufacturing.
Revathy Pharma Pvt Ltd is unlisted.
The authorized capital of Revathy Pharma Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹0.39 M.
The compliance status of Revathy Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX